Open AccessCons: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?
Author(s) -
Giulio Metro,
Massimo Di Maïo
Publication year - 2018
Publication title -
translational lung cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 41
eISSN - 2226-4477
pISSN - 2218-6751
DOI - 10.21037/tlcr.2018.07.11
Subject(s) - medicine , lung cancer , immunotherapy , cancer immunotherapy , cons , cancer , treatment of lung cancer , cancer research , oncology , computer science , programming language